IV Tubing Sets & Accessories Market Size, Share & Trends Analysis Report By Product (Primary IV Tubing Sets, IV Tubing Accessories), By Application, By End Use, By Region, And Segment Forecasts, 2024 - 2030

IV Tubing Sets & Accessories Market Trends

The global IV tubing sets & accessories market size was estimated at USD 1.18 billion in 2023 and is projected to grow at a CAGR of 4.94% from 2024 to 2030, due to the rising prevalence of chronic diseases, advancements in healthcare infrastructure, technological innovations, and the increasing demand for home healthcare. Moreover, there is a growing trend towards home-based care and outpatient services due to convenience, cost-effectiveness, and the reduced risk of hospital-acquired infections. Portable and user-friendly IV products facilitate this trend, increasing demand for IV tubing sets and accessories suitable for home use.

The increasing incidence of chronic diseases such as diabetes, cancer, and cardiovascular conditions is primarily driving the market growth. According to the CDC report published in February 2024, an estimated 129 million people in the U.S. have at least one major chronic disease, such as cancer, heart disease, obesity, diabetes, and hypertension. Chronic diseases often require long-term treatment and management, which frequently involves intravenous (IV) therapy for medication administration, hydration, and nutrition. As a result, the demand for reliable and efficient IV tubing sets and accessories has surged, propelling market growth.

The shift towards home healthcare, accelerated by the COVID-19 pandemic, has significantly impacted the market growth. Home healthcare services provide a cost-effective alternative to hospital stays, particularly for patients requiring long-term IV therapy. Companies like B. Braun Melsungen AG have developed portable and user-friendly IV devices designed for home use, catering to the growing number of patients opting for home-based treatment. This trend is further supported by an aging population that prefers the comfort and convenience of home healthcare, thereby driving market growth.

Technological advancements in the design and manufacturing of IV tubing sets and accessories contribute to market growth. Innovations such as needleless connectors, anti-kink tubing, and smart IV pumps enhance IV therapy's safety, efficiency, and convenience. For instance, advancements in smart IV pumps with integrated software, like Becton Dickinson's Alaris system, provide precise control over medication delivery and improve clinical outcomes. Such innovations attract healthcare providers to upgrade IV therapy equipment, boosting market demand.

Market Concentration & Characteristics

The market is characterized by moderate growth with an accelerating pace, driven by innovation, mergers and acquisitions (M&A), regulatory impacts, service substitutes, and geographic expansion. These factors collectively contribute to the dynamic nature of the market, shaping its current and future landscape.

Innovation in the global market is a significant growth driver. Companies continuously develop advanced products to enhance patient safety, efficacy, and user convenience. For instance, introducing needleless IV systems, such as Baxter International's Clearlink Needleless IV Admin set, reduces the risk of needlestick injuries and infections. These innovations meet the evolving needs of healthcare providers and comply with stringent safety standards, accelerating market adoption.

M&A activities are prominent in the global market, reflecting strategic moves by companies to expand their product portfolios, enhance technological capabilities, and increase market share. For instance, in February 2022, ICU Medical acquired the Smiths Medical Division, which includes ambulatory infusion devices, syringes, vital care products, and vascular access. The acquisition includes ICU Medical's infusion therapy line, including infusion systems, sets, IV solutions, and associated services and software. Such mergers and acquisitions enable companies to leverage synergies, optimize production processes, and strengthen their competitive positions. The ongoing consolidation trend underscores the market's dynamism and potential for growth through strategic partnerships and acquisitions.

Regulations are crucial in shaping the global market. Regulatory bodies, such as the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA), enforce strict guidelines to ensure the safety and efficacy of medical devices. These regulations drive innovation and quality improvements, as companies must adhere to rigorous product development and approval standards. For instance, the Medical Device Regulation (MDR) in the European Union, which occurred in 2021, requires more comprehensive clinical evidence and post-market surveillance for medical devices, including IV tubing sets. Compliance with these regulations enhances product reliability and patient safety, fostering market growth by building trust among healthcare providers and patients.

Regional expansion is a key growth strategy for IV tubing sets and accessories companies. Emerging economies, particularly in Asia-Pacific and Latin America, present significant opportunities due to increasing healthcare investments, rising prevalence of chronic diseases, and expanding healthcare infrastructure. For instance, China's ongoing healthcare reform tasks in 2024 and substantial government investments in healthcare facilities have bolstered the demand for advanced medical devices, including IV tubing sets. Companies are establishing manufacturing facilities and distribution networks in these regions to capitalize on the growing demand.

Product Insights

The primary IV tubing sets segment led the market with the largest revenue share of 32.2% in 2023, due to their essential role in diverse medical procedures, continuous advancements in product design and materials, and cost-effectiveness. Primary IV tubing sets' critical role in acute and chronic care settings underscores their importance. In emergency care, they enable rapid administration of lifesaving medications and fluids. In chronic care, they facilitate long-term treatments for conditions such as cancer, where patients require regular infusions of chemotherapy drugs. Primary IV tubing sets are relatively inexpensive compared to specialized IV accessories and advanced medical devices. Their cost-effectiveness is a crucial factor, especially in resource-constrained healthcare settings. Hospitals and clinics can procure these essential items in large quantities without significant financial strain, ensuring they are readily available for various medical procedures. This affordability and their critical role in patient care contribute to their large market share.

The extension IV tubing sets segment is expected to grow at the fastest CAGR of 5.6% during the forecast period, due to their flexibility and ease of access during IV therapy. They allow for better maneuverability and positioning of the patient, especially in critical care and surgical settings. For instance, in intensive care units (ICUs), extension IV tubing sets facilitate the management of multiple IV lines, reducing the risk of line entanglement and enhancing patient care. Modern extension sets are designed with advanced materials that reduce the risk of kinking and occlusions, ensuring an uninterrupted flow of fluids and medications. Companies such as ICU Medical and Smiths Medical introduced extension IV tubing sets with integrated safety mechanisms such as anti-reflux valves and needleless connectors, which minimize the risk of infections and needle-stick injuries. These technological improvements enhance the reliability and safety of IV therapy, driving market growth.

Application Insights

Based on application, the peripheral intravenous catheter insertion segment led the market with the largest revenue share of 48.5% in 2023, due to its widespread use in various medical settings, advancements in catheter design and materials, and the increasing adoption of minimally invasive procedures. Technological advancements have led to the development of peripheral IV catheters with improved designs and materials that enhance patient safety and comfort. Modern catheters are made from biocompatible materials that reduce the risk of phlebitis and other complications. Innovations such as closed-system IV catheters with built-in safety features, like needleless connectors and anti-reflux valves, minimize the risk of infections and needle-stick injuries. Companies such as Becton Dickinson (BD) and Smiths Medical have introduced advanced peripheral IV catheters that incorporate these safety features, improving clinical outcomes and driving market growth.

The central venous catheter (CVC) placement segment is expected to grow at the fastest CAGR of 5.3% during the forecast period. This growth can be attributed to their crucial role in managing severe and chronic medical conditions and the rising demand for long-term intravenous therapy. For instance, patients with chronic kidney disease undergoing hemodialysis require reliable vascular access, which is often provided by tunneled or non-tunneled CVCs. Similarly, patients with gastrointestinal disorders requiring long-term parenteral nutrition benefit from the use of CVCs. This increasing demand for long-term IV therapy solutions support the robust growth of the CVC placement market.

End Use Insights

Based on end use, the hospitals segment led the market with the largest revenue share of 45.02% in 2023. This significant market share is attributed to several critical factors, including the high volume of surgical procedures, the prevalence of chronic diseases, the availability of advanced healthcare infrastructure, the concentration of specialized medical staff, and the role of hospitals in managing complex and critical care cases. Hospitals are primary centers for treating and managing chronic diseases such as cancer, diabetes, and cardiovascular conditions. The Influenza Hospitalization Surveillance Network reported about 3,262 lab-confirmed influenza-associated hospitalizations between October 1, 2021, and April 23, 2022, while the cumulative hospitalization rate was around 11.1 per 100 thousand individuals. The demand for IV tubing sets and accessories is inherently high in these settings due to the necessity of administering anesthesia, medications, and fluids during and after surgeries.

The ambulatory surgical centers are expected to grow at the fastest CAGR of 5.6% during the forecast period, due to the rising number of outpatient surgical procedures, technological advancements, shifting patient preferences, and expansion of healthcare infrastructure. ASCs are becoming increasingly popular due to their cost-effectiveness and convenience. Procedures that once required hospital stays are now being performed on an outpatient basis, reducing healthcare costs and improving patient turnover. This shift benefits patients through lower costs and shorter recovery times and frees up hospital resources for more critical cases. As a result, the demand for IV tubing sets in ASCs is rising, as these procedures often require administering anesthesia, fluids, and medications. 

Regional Insights

North America dominated the IV tubing sets & accessories market with a largest revenue share of 45.29% in 2023, driven by the high prevalence of chronic diseases, an aging population, technological advancements, the expansion of home healthcare services, and the impact of the COVID-19 pandemic. According to the data published by the Urgent Care Association in May 2024, approximately 14,714 urgent care centers in the U.S. offer diagnostic services and care to more than 100 million patients annually. Moreover, stringent regulations and standards by agencies such as the FDA ensure high-quality and reliable IV tubing sets, fostering trust and widespread adoption.

U.S. IV Tubing Sets & Accessories Market Trends

The IV tubing sets & accessories market in U.S. is experiencing significant growth, driven by the increasing incidence of chronic diseases such as cancer, diabetes, and cardiovascular conditions, which demand extensive use of intravenous therapies. As the population ages, the need for effective and reliable IV treatments continue to rise, bolstering market growth. The National Library of Medicine reported that in July 2021, nearly nine major surgeries were performed for every 100 older people in the U.S., and over one in seven Medicare beneficiaries underwent a major surgery over five years, representing nearly 5 million unique older people. This substantial increase in surgical cases underscores the growing demand for reliable and high-quality IV tubing sets. In addition, the ongoing advancements in medical technology play a crucial role.

Europe IV Tubing Sets & Accessories Market Trends

The IV tubing sets & accessories market in Europe is anticipated to grow at the fastest CAGR during the forecast period. Advancements in medical technology, demographic changes, and evolving healthcare practices characterize the European market. The European Medicines Agency (EMA) and other national regulatory bodies enforce rigorous standards for the safety and efficacy of medical devices, including IV tubing sets and accessories. These regulations ensure high-quality products in the market, fostering trust among healthcare providers and patients and supporting market growth.

Asia Pacific IV Tubing Sets & Accessories Market Trends

The IV tubing sets & accessories market in Asia Pacific is anticipated to witness at a significant CAGR over the forecast period, owing to the region's rapidly growing population, coupled with an increasing incidence of chronic diseases such as diabetes, cancer, and cardiovascular conditions, which drive the demand for intravenous therapies. With a population exceeding 1.4 billion, China faces increasing healthcare demands, including a rising number of surgical procedures. This demographic shift underscores the critical role that IV therapies play in enabling precise and efficient interventions. Moreover, economic development across the region also plays a critical role. As countries like China, India, and Southeast Asian nations experience economic growth, healthcare expenditure has a corresponding increase.

The India IV tubing sets & accessories market is experiencing significant growth, driven by increasing healthcare expenditure, rising surgical procedures, advancements in medical technology, and supportive government initiatives. This robust growth trajectory reflects India's expanding healthcare infrastructure and the growing demand for quality medical therapies. According to The Indian Express, in January 2024, India conducts approximately 30 million surgeries yearly, primarily in small- and mid-size hospitals (85.0%), compared to corporate hospitals (15.0%).

Key IV Tubing Sets & Accessories Company Insights

Prominent players in the market include Baxter; B. Braun Medical, Inc.; Fresenius Kabi AG; and ICU Medical, Inc. Key players are involved in adopting strategies such as mergers, acquisitions, agreements, product launches, and partnerships to strengthen their position in the global market.

Recent Developments

• In May 2024, B. Braun Medical Inc. launched the B Braun Primary IV Administration Set that offers an 85-inch tubing solution with a 15-drop per milliliter drip rate. It features a universal design, roller and side clamps, a Spin-Lock connector, and DEHP-free tubing to protect patients from carcinogenic side effects. The product is compatible with most IV accessories and products

• In January 2024, Convatec Group Plc expanded its Neria Guard subcutaneous infusion set for Parkinson's disease patients. The all-in-one infusion set, which connects to a pump and user's infusion site, offers automatic insertion at the touch of a button, making it easier for patients with dexterity issues.

• In July 2023, Convatec Group Plc partnered with Tandem Diabetes Care to develop the world’s smallest, most durable, automated insulin delivery system, featuring a five-inch infusion set for Tandem Mobi. The 200-unit pump offers enhanced wearability and flexibility, allowing users to disconnect as needed and control the device via a smartphone. This innovative system, FDA 510(k) cleared, can be worn in a coin pocket, clipped to clothing, or adhered directly to the body with an adhesive sleeve

• In September 2021, B. Braun Medical Inc. introduced a series of IV devices in the U.S. market, notable for being the first of their kind not made with PVC and DEHP. These devices offer health benefits to patients from potential exposure risks added environmental protection 

IV Tubing Sets & Accessories Market Report Scope

Global IV Tubing Sets & Accessories Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2018 to 2030. For this report, Grand View Research has segmented the global IV tubing sets & accessories market report based on product, application, end use, and regions.

• Product Outlook (Revenue, USD Billion, 2018 - 2030)

  • Primary IV Tubing Sets

  • Secondary IV Tubing Sets

  • Extension IV Tubing Sets

  • IV Tubing Accessories

  • Others

• Application Outlook (Revenue, USD Billion, 2018 - 2030)

  • Peripheral Intravenous Catheter Insertion

  • Central Venous Catheter Placement

  • PICC Line Insertion

• End Use Outlook (Revenue, USD Billion, 2018 - 2030)

  • Hospitals

  • Clinics

  • Ambulatory Surgery Centers

  • Others

• Regional Outlook (Revenue, USD Billion, 2018 - 2030)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • South Korea

    • Australia

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait